+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Blood Transfusion Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 185 Pages
  • June 2025
  • Region: Global
  • TechSci Research
  • ID: 5439257
UP TO OFF until Jul 31st 2025
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Blood Transfusion Devices Market was valued at USD 4.80 Billion in 2024, and is expected to reach USD 6.61 Billion by 2030, rising at a CAGR of 5.68%. Blood transfusion devices, which include blood bags, transfusion filters, infusion pumps, and apheresis systems, are vital for ensuring the safe and efficient collection, processing, and administration of blood components. The increasing prevalence of medical conditions such as anemia, cancer, hemophilia, and kidney disease - which often necessitate recurrent transfusions - is a key factor propelling market growth.

Additionally, the rise in emergency cases, including trauma and obstetric complications, particularly in developing nations with expanding healthcare systems, continues to drive demand. While financial and logistical challenges remain, the market outlook is positive due to technological advancements, increased healthcare spending, and heightened focus on safety and efficiency in transfusion practices. As both developed and emerging markets enhance their healthcare infrastructure, the integration of advanced transfusion technologies is set to accelerate.

Key Market Drivers

Growth in Healthcare Industry

The expanding global healthcare industry is a key driver supporting the growth of the blood transfusion devices market. Generating over USD 4 trillion annually, the healthcare sector includes pharmaceuticals, biotechnology, medical technology, and diagnostics - each playing a pivotal role in supporting transfusion needs.

Rising rates of surgical procedures, organ transplants, cancer treatments, and emergency interventions require reliable access to blood components like red cells, platelets, and plasma. However, disparities remain - only 6% of the 313 million global procedures occur in the poorest regions, despite these areas housing over a third of the global population. This imbalance results in higher fatality rates for treatable conditions. With more hospitals and clinics being established, especially in underserved regions, demand for transfusion equipment continues to rise, driven by both clinical need and improvements in infrastructure.

Key Market Challenges

High Capital and Operational Costs

The significant costs associated with blood transfusion equipment remain a major challenge for market expansion. Advanced technologies have improved the quality and safety of transfusion procedures but have also raised the financial barriers for adoption.

Establishing modern transfusion facilities requires substantial investment in equipment such as apheresis machines, automated processing systems, and temperature-controlled storage units. In low- and middle-income countries, these upfront and ongoing operational costs often hinder adoption, limiting the reach of quality transfusion care. Budget constraints among healthcare providers further exacerbate disparities in access, affecting both availability and patient outcomes.

Key Market Trends

Expansion of Decentralized Blood Collection Models

An important trend shaping the blood transfusion devices market is the transition toward decentralized collection models. To improve the resilience and reach of blood supply systems, healthcare systems are increasingly deploying mobile collection units, community-based sites, and rural health posts in addition to central facilities.

Innovations such as Touch Activated Phlebotomy (TAP) devices are enhancing the convenience and safety of decentralized blood collection by enabling painless, reliable, and self-administered capillary blood draws - without the need for trained phlebotomists. These models offer scalable, flexible solutions for broader population coverage, especially in hard-to-reach areas.

Key Market Players

  • Immucor Inc.
  • Becton Dickinson and Company
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Grifols SA
  • Kaneka Corporation
  • Fresenius Kabi AG
  • Haemonetics Corporation
  • Macopharma SA
  • Ecomed Solutions, LLC.

Report Scope

In this report, the Global Blood Transfusion Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Transfusion Devices Market, By Product:

  • Apheresis Systems
  • Infusion Devices
  • Blood Warmers
  • Venous Access Devices
  • Filters
  • Others

Blood Transfusion Devices Market, By End Use:

  • Hospital
  • Ambulatory Surgical Centers
  • Dialysis Centers
  • Blood Bank
  • Others

Blood Transfusion Devices Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Transfusion Devices Market.

Available Customizations

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Blood Transfusion Devices Market
5. Global Blood Transfusion Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others)
5.2.2. By End Use (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Blood Transfusion Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By End Use
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Blood Transfusion Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By End Use
6.3.2. Mexico Blood Transfusion Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By End Use
6.3.3. Canada Blood Transfusion Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By End Use
7. Europe Blood Transfusion Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By End Use
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Blood Transfusion Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By End Use
7.3.2. Germany Blood Transfusion Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By End Use
7.3.3. United Kingdom Blood Transfusion Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By End Use
7.3.4. Italy Blood Transfusion Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By End Use
7.3.5. Spain Blood Transfusion Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By End Use
8. Asia Pacific Blood Transfusion Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By End Use
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Blood Transfusion Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By End Use
8.3.2. India Blood Transfusion Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By End Use
8.3.3. South Korea Blood Transfusion Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By End Use
8.3.4. Japan Blood Transfusion Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By End Use
8.3.5. Australia Blood Transfusion Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By End Use
9. South America Blood Transfusion Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By End Use
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Blood Transfusion Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By End Use
9.3.2. Argentina Blood Transfusion Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By End Use
9.3.3. Colombia Blood Transfusion Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By End Use
10. Middle East and Africa Blood Transfusion Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By End Use
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Blood Transfusion Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By End Use
10.3.2. Saudi Arabia Blood Transfusion Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By End Use
10.3.3. UAE Blood Transfusion Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Disruptions : Conflicts, Pandemics and Trade Barriers14. Global Blood Transfusion Devices Market: SWOT Analysis
15. Porters Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. Competitive Landscape
16.1. Immucor Inc.
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.1.6. Key Personnel Details
16.1.7. SWOT Analysis
16.2. Becton Dickinson and Company
16.3. B. Braun Melsungen AG
16.4. Terumo Corporation
16.5. Grifols SA
16.6. Kaneka Corporation
16.7. Fresenius Kabi AG
16.8. Haemonetics Corporation
16.9. Macopharma SA
16.10. Ecomed Solutions, LLC.
17. Strategic Recommendations18. About the Publisher & Disclaimer

Companies Mentioned

  • Immucor Inc.
  • Becton Dickinson and Company
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Grifols SA
  • Kaneka Corporation
  • Fresenius Kabi AG
  • Haemonetics Corporation
  • Macopharma SA
  • Ecomed Solutions, LLC.

Table Information